Abdullaev A A, Kuznetsov A N, Liusov V A
Ter Arkh. 1995;67(6):11-4.
Plasmosorption and enterosorption were assigned to 35 acute myocardial infarction (AMI) patients. Plasmosorption was performed within an hour since AMI onset followed by a 5-day course of enterosorption (enterosorbent YO-A in a dose 30 g/day). The above combination produced a positive effect on hemodynamics and blood rheology resultant from a reduction in hematocrit value, plasma levels of fibrinogen and its derivatives, plasma viscosity and platelet aggregation. Ibustrin (200 mg) combined with heparin (100000 U) introduced into extracorporeal circulation effectively prevents thrombogenesis. AMI patients treatment with enterosorption plus plasmosorption enhances the response to nitroglycerin, reduces the rate of complications and lethal outcomes.
对35例急性心肌梗死(AMI)患者进行了血浆吸附和肠吸附治疗。在急性心肌梗死发作后1小时内进行血浆吸附,随后进行为期5天的肠吸附疗程(服用剂量为30克/天的肠吸附剂YO - A)。上述联合治疗对血流动力学和血液流变学产生了积极影响,这是由于血细胞比容值、血浆纤维蛋白原及其衍生物水平、血浆粘度和血小板聚集降低所致。将伊布司特(200毫克)与肝素(100000单位)联合引入体外循环可有效预防血栓形成。对急性心肌梗死患者采用肠吸附加血浆吸附治疗可增强对硝酸甘油的反应,降低并发症发生率和致死率。